NCT00202579已完成2 期
Evaluation of the Effects on Peripheral and Central Haemodynamics Parameters, Safety, and Tolerance of Three-hour Intravenous Perfusion (0.1 mg/kg) of Ivabradine Given to Severe Congestive Heart Failure Patients
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 12
- 试验地点
- 2
- 主要终点
- Haemodynamic parameters
研究概览
简要总结
To evaluate the effects on heart function of ivabradine administered to patients with severe chronic heart failure
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •systolic congestive heart failure
- •sinus rhythm, HR >= 80bpm
排除标准
- •unstable cardiovascular condition
结局指标
主要结局
Haemodynamic parameters
Twelve-lead ECG
Systolic and diastolic blood pressure
次要结局
- Neurohormones
- Echocardiography
研究者
研究点 (2)
Loading locations...
相似试验
已完成
3 期
Effects of Ivabradine in Patients With Stable Coronary Artery Disease Without Clinical Heart FailureCoronary Artery DiseaseNCT02446990Institut de Recherches Internationales Servier19,102
已完成
2 期
Efficacy of Oral Ivabradine in Patients Presenting With NSTEMINSTEMINCT04285736Cairo University100
Unknown
4 期
Ivabradine in Patients With an Unsatisfactory Percentage of Cardiac Resynchronization TherapyHeart FailureNCT02166060Medical University of Warsaw60
已完成
3 期
The BEAUTIFUL Study: Effects of Ivabradine in Patients With Stable Coronary Artery Disease and Left Ventricular Systolic DysfunctionCoronary DiseaseVentricular Dysfunction, LeftNCT00143507Institut de Recherches Internationales Servier10,917
Unknown
4 期
Clinical Study of CMR to Evaluate the Effect of Ivabradine on the Improvement of Left Ventricular Remodeling in STEMI Patients After Primary PCICardiovascular DiseasesNCT05348057Qian geng240